EntreMed Issued Broad Angiostatin Patent

EntreMed, Inc. announced that U.S. Patent No. 6,025,688 has been issued covering all antiangiogenic fragments and methods of production for its potent angiogenesis inhibitor, angiostatin protein.

The patent also covers antiangiogenic fragments of angiostatin protein that may contain amino acid additions, deletions, or substitutions, which means that any products developed through alterations to the parent molecule are now covered under EntreMed’s intellectual property.

Angiostatin is known as an endogenous, or naturally-occurring, molecule because its parent molecule, plasminogen, is a component of blood.

With issuance of this patent, EntreMed now has patent protection covering all forms of the angiostatin molecule, whether used as a protein, peptide fragment, or gene for delivery to a patient.

The patent also covers angiostatin produced in a patient after the administration of drugs used to convert plasminogen into antiangiogenic fragments of angiostatin.

To provide the broadest intellectual property portfolio around the angiostatin molecule, EntreMed has pursued an aggressive patent protection strategy.

Since 1994, nine angiostatin patents have issued covering use of the molecule as a diagnostic and prognostic agent and for the treatment of angiogenesis-mediated diseases, such as cancer, heart disease, and blindness.

Seven more patents are pending.

On August 27, 1998 EntreMed announced the issuance of U.S. Patent No. 5,792,845 for composition of matter claims for the gene encoding angiostatin.

The earlier patent covers the gene used to produce angiostatin protein and also includes vectors that may be used to deliver gene therapy to patients.

Patent coverage for the angiostatin gene itself means that EntreMed can explore next-generation drug delivery systems by inserting the gene that encodes for angiostatin into a patient triggering the body to manufacture angiostatin in concentrations sufficient to block the growth of new blood vessels involved in disease promotion.

If successful as a drug delivery system, this method could potentially eliminate the need for daily drug injections in the future.

EntreMed’s Chairman, President and CEO, Dr. John W. Holaday, commented: “Issuance of this important patent ensures that EntreMed can vigorously protect its intellectual property position while encouraging other scientists to perform critical research with angiostatin. We encourage and support extended research with angiostatin protein, its protein fragments, genes, and gene fragments in order to expand the knowledge base around this potent antiangiogenic agent.”

Shop Steroids

dragon-pharmaceutical
Dragon Pharma has provided our customers the highest level of pharmacy services throughout the continuum of the overall healthcare system: Masteron for Sale.

Shop Dragon Pharmaceuticals Safely

Masteron 100 - Cheap Price

Administration: Injection
Active Component: Drostanolone Di-Propionate
Branded by: Dragon Pharmaceuticals
Package: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $42.00

Clenbuterol

Beta-2 Agonist, Bronchodilator
Base Chemical Name: Clenbuterol Hydrochloride
Produced by: Dragon Pharma
Package: 1 X 100 tabs (40 mcg/tablet)

Oxymetholon - Discount Price

Administration: Oral
Base Constituent: Oxymetholone
Manufacturer: Dragon Pharma Labs
Package: 30 x 100 tabs (50 mg/pill)
Price: 30 x $51.00

Winstrol Depot

Injectable Anabolic Steroid
Basic Ingredient: Stanozolol
Branded by: Dragon Pharmaceutical
Pack: 1 X 10 ml (50 mg/ml)

EQ 200 / Test E 200

Injectable Anabolic Steroid
Basic Chemical Name: Boldenone Undecylenate, Testosterone Enanthate
Made by: Dragon Pharmaceuticals
Package: 1 X 10 mL vial (400 mg/mL)

Cut Long 300

Injectable Anabolic Steroid
Primary Constituent: Drostanolone Enanthate, Testosterone Enanthate, Trenbolone Enanthate
Produced by: Dragon Pharma LLC
Amount: 1 X 10 ml (300 mg/ml)

TriTren 150 - Cheap Price

Administration: Injection
Base Component: Tri Trenbolone
Made by: Dragon Pharma Labs
Pack: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $65.00

Winstrol Tabs

Oral Steroid for Muscle Growth
Primary Constituent: Stanozolol
Manufacturer: Dragon Pharma Labs
100 tablets (50 mg/tablet)

Trenbolone 100 [10 Vials]

Injectable Steroid for Muscle Growth
Basic Component: Trenbolone Acetate
Produced by: Dragon Pharmaceutical
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $60.00 = $600.00 in Total

1-Test Cyp 200

Injectable Steroid for Muscle Growth
Primary Component: Dihydroboldenone Cypionate
Made by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (200 mg/mL)

Deca 300 [10 Vials]

Injectable Steroid for Muscle Growth
Base Constituent: Nandrolone Decanoate
Producer: Dragon Pharmaceutical
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $45.00 = $450.00 in Total

Primobolan 200

Principal Component: Methenolone Enanthate
Branded by: Dragon Pharma
Package: 10 mL vial (200 mg/mL)